UCD Home | About UCD | UCD News & Events | Virtual Tour | Contact UCD | Staff Directories | UCD Sitemap | UCD Connect

European Projects

Prof. Kenneth Dawson, Director of CBNI has coordinated over five EU FP6 and FP7 projects in recent years and currently coordinates three EU FP7 programs including a large infrastructure project “QualityNano (QNano)  -  A Pan European Infrastructure for Quality in Nanomaterials Safety Testing” and two small collaborative projects “NeuroNano” and “NanoTransKinetics”. CBNI is also partner in five other EU FP7 programs coordinated by Institutes in Europe “Namdiatream”, “3MICRON”, “BisNano”, “NanoTOES” and “NanoImpactNet”, for further information on these projects please click on “Other Projects” below.

The Graphene Flagship aims to bring together academic and industrial researchers to take graphene from the realm of academic laboratories into European, thus generating economic growth, new jobs and new opportunities. The core consortium consists of over 150 academic and industrial research groups in 23 countries.

The initiative has received funding from the European Union FP7 and H2020 funding programmes.

CALIN (Celtic Advanced Life Science Innovation Network) is an Ireland Wales 2014-2020 programme part funded by the European Regional Development Fund through the Welsh Government. CALIN aims to engage and assist Small and Medium-sized Enterprises (SMEs) in the life sciences sectors across Ireland and Wales by offering open access to a unique strategic international partnership involving six world-leading higher educational institutions. The six higher educational institutions are; the programme coordinator Swansea University, Bangor University and Cardiff University in Wales, and University College Dublin, National University of Ireland Galway (NUI Galway), Tyndall National Institute in Ireland.


A framework to respond to the regulatory needs of future nanomaterials and markets.

QCM for rapid label-free Bionano interface evaluation and screening of effectiveness of nano-targeting strategies for therapeutics.

Nanofacturing aims to design and build both pilot and large-scale manufacturing lines for the production of nanopharmaceuticals. The project focuses on the scale up of glycan-coated nanoparticles, the latest generation of nanomedicines, and addresses the bottlenecks in the delivery of these medicines to the market.

Nanofacturing has received funding from the European Union H2020 research and innovation programme.

Nanostreem aims to develop a better understanding of the occupational hazards related to the use of nanomaterials and a better governance of the risks related to the manipulation of nanomaterials on the workers and environment using the semiconductor industry as an example.

Nanostreem has received funding from the European Union H2020 research and innovation programme.

Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers.